-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$74.67449.85% Upside
Novavax, Inc. Frequently Asked Questions
-
What analysts cover Novavax, Inc.?
Novavax, Inc. has been rated by research analysts at Jefferies, H.C. Wainwright, Cantor Fitzgerald in the past 90 days.